Nexgen Biotech claims that its bioengineered synthetic spider venom and botulinum toxin (BTX) alternative product have ‘huge potential’ for cosmetics markets in Korea and beyond, covering areas from anti-ageing to wound-healing.
Incospharm has launched an autophagy-inducing active that restores the skin’s hydrolipidic film to tackle acne at the recent in-cosmetics Korea trade show. Sebodulin is the latest in Incospharm’s portfolio of autophagy-activating peptides.
A unique pharmacy-backed trial, one of the largest medical studies of its kind ever undertaken in New Zealand, has shown that honey derived from New Zealand's kānuka trees is as effective in healing cold sores as pharmaceutical anti-viral treatments.
This week’s two-day Cosmetics Design Summit on Skin Care Microbiome Innovation concluded with a panel discussion to explore whether the microbiome trend is a fad or here for the long-term. The consensus was unanimous…